JUBLPHARMAPharmaceuticals
Jubilant Pharmova Ltd — Balance Sheet
₹816.45
-1.80%
Jubilant Pharmova Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Treasury Shares Number | 0.09 Cr | 0.09 Cr | 0.02 Cr | — | 0.01 Cr |
| Ordinary Shares Number | 15.84 Cr | 15.84 Cr | 15.91 Cr | 15.93 Cr | — |
| Share Issued | 15.93 Cr | 15.93 Cr | 15.93 Cr | 15.93 Cr | — |
| Net Debt | 1.35K Cr | 2.46K Cr | 2.40K Cr | 1.95K Cr | — |
| Total Debt | 2.73K Cr | 3.66K Cr | 3.68K Cr | 3.19K Cr | — |
| Tangible Book Value | 2.62K Cr | 1.93K Cr | 2.02K Cr | 2.15K Cr | — |
| Invested Capital | 8.69K Cr | 8.85K Cr | 8.81K Cr | 8.25K Cr | — |
| Working Capital | 1.41K Cr | 1.99K Cr | 1.99K Cr | 1.92K Cr | — |
| Net Tangible Assets | 2.62K Cr | 1.93K Cr | 2.02K Cr | 2.15K Cr | — |
| Capital Lease Obligations | 294.10 Cr | 249.90 Cr | 266.70 Cr | 264.39 Cr | — |
| Common Stock Equity | 6.25K Cr | 5.43K Cr | 5.40K Cr | 5.32K Cr | — |
| Total Capitalization | 8.41K Cr | 8.60K Cr | 8.51K Cr | 7.78K Cr | — |
| Total Equity Gross Minority Interest | 6.24K Cr | 5.42K Cr | 5.39K Cr | 5.32K Cr | — |
| Minority Interest | -16.30 Cr | -12.80 Cr | -7.50 Cr | -2.16 Cr | — |
| Stockholders Equity | 6.25K Cr | 5.43K Cr | 5.40K Cr | 5.32K Cr | — |
| Other Equity Interest | 6.24K Cr | 14.50 Cr | 6.20 Cr | 3.66 Cr | — |
| Capital Stock | 15.80 Cr | 15.80 Cr | 15.90 Cr | 15.92 Cr | — |
| Common Stock | 15.80 Cr | 15.80 Cr | 15.90 Cr | 15.92 Cr | — |
| Total Liabilities Net Minority Interest | 6.52K Cr | 6.13K Cr | 5.76K Cr | 4.67K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 4.35K Cr | 4.24K Cr | 3.99K Cr | 3.08K Cr | — |
| Other Non Current Liabilities | 1.14K Cr | 543.80 Cr | 268.51 Cr | 7.30 Cr | — |
| Non Current Deferred Taxes Liabilities | 172.20 Cr | 210.80 Cr | 306.20 Cr | 302.96 Cr | — |
| Long Term Debt And Capital Lease Obligation | 2.39K Cr | 3.36K Cr | 3.32K Cr | 2.68K Cr | — |
| Long Term Capital Lease Obligation | 238.50 Cr | 197.80 Cr | 213.30 Cr | 212.19 Cr | — |
| Long Term Debt | 2.15K Cr | 3.17K Cr | 3.11K Cr | 2.46K Cr | — |
| Long Term Provisions | 119.10 Cr | 100.10 Cr | 92.20 Cr | 95.67 Cr | — |
| Current Liabilities | 2.16K Cr | 1.89K Cr | 1.77K Cr | 1.59K Cr | — |
| Other Current Liabilities | 202.10 Cr | 163.20 Cr | 121.78 Cr | 151.86 Cr | — |
| Current Debt And Capital Lease Obligation | 342.20 Cr | 299.10 Cr | 353.10 Cr | 515.57 Cr | — |
| Current Capital Lease Obligation | 55.60 Cr | 52.10 Cr | 53.40 Cr | 52.19 Cr | — |
| Current Debt | 286.60 Cr | 247.00 Cr | 299.70 Cr | 463.37 Cr | — |
| Current Provisions | 78.40 Cr | 66.40 Cr | 78.30 Cr | 86.84 Cr | — |
| Payables | 1.02K Cr | 1.42K Cr | 1.27K Cr | 897.94 Cr | — |
| Total Tax Payable | 18.40 Cr | 37.00 Cr | 62.40 Cr | 34.51 Cr | — |
| Accounts Payable | 1.00K Cr | 856.30 Cr | 821.30 Cr | 567.74 Cr | — |
| Total Assets | 12.76K Cr | 11.55K Cr | 11.16K Cr | 9.99K Cr | — |
| Total Non Current Assets | 9.18K Cr | 7.67K Cr | 7.39K Cr | 6.48K Cr | — |
| Other Non Current Assets | 19.80 Cr | 0.80 Cr | 0.90 Cr | 0.95 Cr | — |
| Non Current Deferred Taxes Assets | 257.40 Cr | 232.70 Cr | 227.50 Cr | 161.27 Cr | — |
| Investmentin Financial Assets | 62.60 Cr | 34.40 Cr | 32.80 Cr | 43.49 Cr | — |
| Available For Sale Securities | 62.60 Cr | 32.20 Cr | 30.80 Cr | 36.93 Cr | — |
| Long Term Equity Investment | 7.50 Cr | 7.80 Cr | 223.60 Cr | 195.11 Cr | — |
| Investmentsin Associatesat Cost | 7.50 Cr | 7.80 Cr | 223.60 Cr | 195.11 Cr | — |
| Goodwill And Other Intangible Assets | 3.64K Cr | 3.51K Cr | 3.38K Cr | 3.17K Cr | — |
| Other Intangible Assets | 1.10K Cr | 1.04K Cr | 951.00 Cr | 926.32 Cr | — |
| Goodwill | 2.54K Cr | 2.46K Cr | 2.43K Cr | 2.24K Cr | — |
| Net PPE | 5.17K Cr | 3.69K Cr | 3.37K Cr | 2.79K Cr | — |
| Gross PPE | 5.17K Cr | 5.68K Cr | 4.88K Cr | 4.03K Cr | — |
| Construction In Progress | 2.71K Cr | 1.25K Cr | 773.30 Cr | 291.83 Cr | — |
| Other Properties | 2.45K Cr | 2.43K Cr | 2.59K Cr | 2.50K Cr | — |
| Current Assets | 3.58K Cr | 3.88K Cr | 3.76K Cr | 3.51K Cr | — |
| Other Current Assets | 220.60 Cr | 1.00 Cr | 5.60 Cr | 3.29 Cr | — |
| Assets Held For Sale Current | 67.50 Cr | 243.90 Cr | 0.00 | — | 0.00 |
| Inventory | 1.13K Cr | 1.29K Cr | 1.38K Cr | 1.25K Cr | — |
| Other Receivables | 1.10 Cr | 335.00 Cr | 246.90 Cr | 214.41 Cr | — |
| Taxes Receivable | 18.00 Cr | 16.70 Cr | 11.60 Cr | 0.18 Cr | — |
| Accounts Receivable | 891.50 Cr | 915.90 Cr | 961.20 Cr | 927.99 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 1.25K Cr | 962.60 Cr | 1.02K Cr | 985.62 Cr | — |
| Other Short Term Investments | 161.00 Cr | 8.70 Cr | 4.40 Cr | 5.35 Cr | — |
| Cash And Cash Equivalents | 1.09K Cr | 953.90 Cr | 1.01K Cr | 980.26 Cr | — |
| Retained Earnings | — | 4.54K Cr | 4.54K Cr | 4.69K Cr | 4.32K Cr |
| Additional Paid In Capital | — | 39.80 Cr | 39.80 Cr | 39.84 Cr | 39.84 Cr |
| Tradeand Other Payables Non Current | — | 18.80 Cr | 1.90 Cr | 0.50 Cr | 19.45 Cr |
| Non Current Deferred Revenue | — | 543.80 Cr | 268.50 Cr | 7.30 Cr | 7.57 Cr |
| Other Payable | — | 527.90 Cr | 382.30 Cr | 292.14 Cr | 262.87 Cr |
| Dividends Payable | — | 2.50 Cr | 3.10 Cr | 3.56 Cr | 4.02 Cr |
| Non Current Prepaid Assets | — | 177.60 Cr | 113.30 Cr | 105.67 Cr | 53.97 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | 2.20 Cr | 2.00 Cr | 6.57 Cr | 9.15 Cr |
| Accumulated Depreciation | — | -2.00K Cr | -1.52K Cr | -1.24K Cr | -992.83 Cr |
| Machinery Furniture Equipment | — | 3.29K Cr | 2.94K Cr | 2.63K Cr | 2.21K Cr |
| Buildings And Improvements | — | 1.05K Cr | 1.08K Cr | 1.02K Cr | 993.76 Cr |
| Land And Improvements | — | 87.90 Cr | 86.30 Cr | 87.51 Cr | 86.94 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 2.90 Cr | 3.50 Cr | 3.97 Cr | 10.22 Cr |
| Prepaid Assets | — | 108.50 Cr | 137.90 Cr | 118.85 Cr | 97.79 Cr |
| Finished Goods | — | 326.70 Cr | 294.50 Cr | 314.61 Cr | 275.54 Cr |
| Work In Process | — | 350.00 Cr | 453.40 Cr | 379.26 Cr | 347.22 Cr |
| Raw Materials | — | 612.90 Cr | 632.60 Cr | 559.67 Cr | 505.48 Cr |
| Allowance For Doubtful Accounts Receivable | — | -66.80 Cr | -50.50 Cr | -25.88 Cr | -21.98 Cr |
| Gross Accounts Receivable | — | 982.70 Cr | 1.01K Cr | 953.87 Cr | 841.88 Cr |
| Cash Equivalents | — | 51.90 Cr | 18.00 Cr | 29.08 Cr | 22.12 Cr |
| Cash Financial | — | 902.00 Cr | 992.80 Cr | 951.19 Cr | 475.81 Cr |
| Other Inventories | — | — | 1.26 Cr | 1.34 Cr | 1.15 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Jubilant Pharmova Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.